Supriya Lifescience Limited (SUPRIYA.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-83.4%

₹139.11

vs ₹836.50 price

Levered DCF

-₹79.27

After debt service

Piotroski score

5 / 9

Average

Altman Z-score

—

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	21.63×	31.34×	24.02×	17.09×	26.16×	23.14×	38.97×	72.51×
P/B	3.78×	5.91×	3.51×	2.19×	6.45×	3.71×	6.69×	10.65×
P/S	5.46×	8.46×	5.13×	3.4×	7.64×	2.59×	3.2×	3.59×
EV / EBITDA	14.72×	21.51×	15.25×	10.75×	17.29×	5.8×	9.93×	15.03×
Gross margin	54.2%	55.2%	50.3%	48.9%	55.7%	60.8%	47.8%	37.5%
Operating margin	32.1%	34.5%	27.6%	25.6%	38.9%	42.7%	44.8%	22.0%
Net margin	25.3%	27.0%	21.4%	19.9%	29.2%	32.1%	23.6%	14.2%
Current ratio	4.4×	5.32×	5.17×	4.85×	4.99×	1.82×	1.27×	0.99×
Debt / equity	0×	0.01×	0.01×	0.03×	0.04×	0.27×	0.57×	0.98×
Interest coverage	140.62×	142.56×	74.01×	37.39×	48.16×	40.3×	20.37×	5.98×
Dividend yield	0.2%	0.1%	0.2%	0.3%	0.1%	0.4%	1.8%	0.0%
Payout ratio	3.8%	3.4%	4.1%	5.4%	2.9%	3.2%	24.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	17.5%	18.9%	14.6%	12.8%	24.7%	46.0%	49.2%	42.0%
Return on invested capital	16.4%	17.6%	13.1%	11.3%	22.5%	32.9%	40.8%	21.1%
Return on assets	15.4%	16.9%	12.9%	11.0%	20.7%	27.7%	21.8%	15.6%
Free cash flow yield	1.0%	0.2%	-1.1%	-2.7%	-0.3%	3.2%	9.2%	4.2%
Earnings yield	4.6%	3.2%	4.2%	5.9%	3.8%	12.4%	7.4%	3.9%
Enterprise value	₹44.9B	₹58.2B	₹28B	₹14.7B	₹38.3B	₹10.3B	₹10.8B	₹10.9B
Net debt / EBITDA	-0.11×	-0.26×	-0.34×	-0.46×	-0.62×	0.16×	0.76×	1.25×
Cash conversion cycle (days)	144	122	110	156	154	141	65	51